|
Match
|
Document |
Document Title |
|
|
US20090191213 |
Compositions and methods for regulating NK cell activity
The present invention relates to novel compositions and methods for regulating an immune response in a subject. More particularly, the invention relates to specific antibodies that regulate the...
|
|
|
US20080187540 |
Antibodies to OCIF-binding molecules
A novel protein which binds to Osteoclastogenesis Inhibitory Factor (OCIF-binding molecule; OBM), a process for preparing the same, DNA encoding said protein, a protein having an amino acid...
|
|
|
US20080166356 |
Pharmaceutical compositions and methods of using secreted frizzled related protein
Pharmaceutical compositions and methods of use in regulation of mammalian bone forming activities of sFRPs (secreted frizzled-related proteins) are disclosed. sFRPs are secreted receptors for Wnts,...
|
|
|
US20080107657 |
ANTIBODIES THAT BIND TO AN EPITOPE ON THE HUNTINGTON'S DISEASE PROTEIN
The present invention relates generally to the generation and characterization of anti-huntingtin antibodies binding an epitope on the Huntington's disease protein. The invention further relates to...
|
|
|
US20080095766 |
Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity
The present invention provides methods of treating, preventing, slowing the progression of, or ameliorating the symptoms of T cell mediated immunological diseases, particularly autoimmune diseases...
|
|
|
US20080089894 |
Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis
The invention relates to methods of inducing tolerance and preventing transplant rejection by blocking costimulatory signals and using immunosuppressive agents, preferably rapamycin, to prevent...
|
|
|
US20080089893 |
THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOLABELLED ANTIBODIES TO HUMAN B LYMPHOCYTE RESTRICTED DIFFERENTIATION ANTIGEN FOR TREATMENT OF B CELL LYMPHOMA
Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of...
|
|
|
US20080075727 |
METHODS OF THERAPY FOR B-CELL MALIGNANCIES USING ANTAGONIST ANTI-CD40 ANTIBODIES
Methods of therapy for B-cell malignancies are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment...
|
|
|
US20080058762 |
Induction And Maintenance Of Tolerance To Composite Tissue Allografts
The present invention provides a clinically-applicable approach for inducing long-term, donor-specific tolerance to donor antigens, especially in recipients of CTA and/or solid organ transplants,...
|
|
|
US20080031881 |
MEDICAMENT FOR TREATING CANCER
|
|
|
US20080031876 |
CTLA4 molecules and IL4-binding molecules and uses thereof
|
|
|
US20080019972 |
Method for Amplifying Therapeutic Vaccine Activity
A method of amplifying activity of therapeutic vaccines including administering an effective amount of a composition including a compound that depletes or inhibits B lymphocytes to a patient...
|
|
|
US20080014174 |
Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte
According to the present invention, HLA matching donor-originating activated lymphocytes highly effective in the treatment of patients with tumors, viral infections and autoimmune diseases are...
|